Financial Review: Sensus Healthcare (SRTS) versus The Competition

Sensus Healthcare (NASDAQ:SRTS) is one of 511 publicly-traded companies in the “Healthcare Equipment & Supplies” industry, but how does it compare to its competitors? We will compare Sensus Healthcare to related businesses based on the strength of its risk, dividends, valuation, profitability, earnings, analyst recommendations and institutional ownership.

Profitability

This table compares Sensus Healthcare and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Sensus Healthcare	-88.45%	-21.57%	-19.20%
Sensus Healthcare Competitors	-278.24%	-150.08%	-21.87%

Risk & Volatility

Sensus Healthcare has a beta of 1.18, suggesting that its share price is 18% more volatile than the S&P 500. Comparatively, Sensus Healthcare’s competitors have a beta of 2.56, suggesting that their average share price is 156% more volatile than the S&P 500.

Institutional & Insider Ownership

25.3% of Sensus Healthcare shares are owned by institutional investors. Comparatively, 40.6% of shares of all “Healthcare Equipment & Supplies” companies are owned by institutional investors. 10.2% of Sensus Healthcare shares are owned by company insiders. Comparatively, 14.9% of shares of all “Healthcare Equipment & Supplies” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a summary of recent ratings and target prices for Sensus Healthcare and its competitors, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sensus Healthcare	1	0	4	0	2.60
Sensus Healthcare Competitors	4264	10495	18232	825	2.46

Sensus Healthcare currently has a consensus price target of $5.83, suggesting a potential upside of 77.30%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 22.95%. Given Sensus Healthcare’s stronger consensus rating and higher possible upside, equities research analysts clearly believe Sensus Healthcare is more favorable than its competitors.

Valuation & Earnings

This table compares Sensus Healthcare and its competitors revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Sensus Healthcare	$27.48 million	-$7.72 million	-3.50
Sensus Healthcare Competitors	$1.88 billion	$139.14 million	10.94

Sensus Healthcare’s competitors have higher revenue and earnings than Sensus Healthcare. Sensus Healthcare is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Summary

Sensus Healthcare competitors beat Sensus Healthcare on 7 of the 13 factors compared.

Sensus Healthcare Company Profile

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.